Toll-like receptor 9 signaling protects against murine lupus

Arthritis and Rheumatism

Volumn 54, Issue 1, 2006, Pages 336-342

  Wu, Xiaobo ^a   Peng, Stanford L ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c Inflammation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN CLASS; RHEUMATOID FACTOR; TOLL LIKE RECEPTOR 9;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROTECTION; CONTROLLED STUDY; CPG ISLAND; GENETIC MODEL; IMMUNOREACTIVITY; IN VITRO STUDY; INFLAMMATORY INFILTRATE; KIDNEY; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MIXED LYMPHOCYTE REACTION; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; SALIVARY GLAND; T LYMPHOCYTE ACTIVATION;

ANIMALS; LUPUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; TOLL-LIKE RECEPTOR 9;

EID: 31044440025     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21553     Document Type: Article

References (28)

1. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-7.
2. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003;19:837-47.
3. Rui L, Vinuesa CG, Blasioli J, Goodnow CC. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nature Immunol 2003;4:594-600.
4. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-60.
5. Lin L, Gerth AJ, Peng SL. CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88. Eur J Immunol 2004;34:1483-7.
6. Poeck H, Wagner M, Battiany J, Rothenfusser S, Wellisch D, Hornung V, et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 2004;103:3058-64.
7. Peng SL. Signaling in B cells via toll-like receptors. Curr Opin Immunol 2005;17:230-6.
8. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005;202:321-31.
9. Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, et al. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J Immunol 1998;161:6999-7006.
10. Nishihara M, Terada M, Kamogawa J, Ohashi Y, Mori S, Nakatsuru S, et al. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. Arthritis Rheum 1999;42:2616-23.
11. lpr mice. J Clin Invest 1998;101:696-702.
12. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992;176:1645-56.
13. + T cell-mediated suppression by dendritic cells. Science 2003;299:1033-6.
14. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118: 229-41.
15. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-5.
16. Peng SL, Craft J. PCR-RFLP genotyping of murine MHC haplotypes. Biotechniques 1996;21:362-8.
17. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-71.
18. Hron JD, Peng SL. Type I interferon protects against murine lupus. J Immunol 2004;173:2134-42.
19. Obermeier F, Strauch UG, Dunger N, Grunwald N, Rath HC, Herfarth HH, et al. In vivo CpG DNA/TLR9 interaction induces regulatory properties in CD4+CD62L+-T-cells which prevent intestinal inflammation in the SCID transfer model of colitis. Gut 2005;54:1428-36.
20. Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004;173:4433-42.
21. Jain VV, Kitagaki K, Businga T, Hussain I, George C, O'Shaughnessy P, et al. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol 2002;110:867-72.
22. Monk CR, Spachidou M, Rovis F, Leung E, Botto M, Lechler RI, et al. MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 2005;52:1180-4.
23. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;296:490-4.
24. Isenberg DA, Katz D, le Page S, Knight B, Tucker L, Maddison P, et al. Independent analysis of the 16/6 idiotype lupus model: a role for an environmental factor? J Immunol 1991;147:4172-7.
25. Leiter EH, Serreze DV, Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol Today 1990;11:147-9.
26. Oishi H, Miyazaki T, Mizuki S, Kamogawa J, Lu LM, Tsubaki T, et al. Accelerating effect of an MRL gene locus on the severity and onset of arthropathy in DBA/1 mice. Arthritis Rheum 2005;52: 959-66.
27. Lin L, Peng SL. Interleukin-18 receptor signaling is not required for autoantibody production and end-organ disease in murine lupus. Arthritis Rheum 2005;52:984-6.
28. Lin L, Gerth AJ, Peng SL. Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor. J Exp Med 2004;200:115-22.